Group 1 - The core viewpoint of the news is the performance and holdings of the Huatai-PineBridge Medical Active Growth One-Year Holding Mixed Fund A, which has experienced a recent decline in net value and varying returns over different time frames [1] - As of May 7, 2025, the fund's latest net value is 0.5813 yuan, reflecting a decrease of 3.61% [1] - The fund's performance over the past month shows a return of 1.12%, ranking 1221 out of 4649 in its category, while the three-month return is 20.24%, ranking 92 out of 4597 [1] - Year-to-date, the fund has achieved a return of 21.59%, ranking 168 out of 4556 [1] Group 2 - The top ten stock holdings of the fund account for a total of 56.30%, with significant positions in companies such as Kelun-Botai (9.63%), BeiGene-U (8.84%), and Kangfang Biotech (7.07%) [1] - The fund was established on August 21, 2020, and as of March 31, 2025, it has a total scale of 1.68 billion yuan [1] - The fund manager, Zheng Lei, has extensive experience in the investment field, having previously worked with various financial institutions and managed multiple funds since joining Huatai-PineBridge in November 2017 [2]
5月7日汇添富医疗积极成长一年持有混合A净值下跌3.61%，近1个月累计上涨1.12%
Sou Hu Cai Jing·2025-05-07 11:35